Markets › LSE › 0KW4.L

ResMed Inc.

LSE:0KW4.LHealthcare

——At close · Market cap — · Next earnings Thu 29 Oct

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Revenue	3.0	3.2	3.6	4.2	4.7	5.1	+9.8%
Cost of revenue	1.2	1.4	1.6	1.9	2.0	2.1	+3.0%
Gross profit	1.7	1.8	2.0	2.4	2.7	3.1	+15.1%
Research & development	0.2	0.2	0.3	0.3	0.3	0.3	+7.7%
Selling, general & administrative	0.7	0.7	0.7	0.9	0.9	1.0	+8.1%
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—
Operating expenses	0.9	0.9	1.0	1.2	1.3	1.4	+2.6%
Operating income	0.8	0.9	1.0	1.1	1.3	1.7	+27.8%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	−72.4%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	—
Other income / expense	(0.1)	(0.0)	(0.0)	(0.0)	(0.1)	(0.0)	+85.8%
Pre-tax income	0.7	0.9	1.0	1.1	1.3	1.7	+32.6%
Income tax	0.1	0.4	0.2	0.2	0.2	0.3	+13.5%
Net income	0.6	0.5	0.8	0.9	1.0	1.4	+37.2%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—
EPS, basic (per share)	4.31	3.27	5.34	6.12	6.94	9.55	+37.6%
EPS, diluted (per share)	4.27	3.24	5.30	6.09	6.92	9.51	+37.4%
EBITDA	1.0	1.1	1.2	1.4	1.5	1.9	+24.8%
Depreciation & amortization	0.2	0.2	0.2	0.2	0.2	0.2	+9.1%
Weighted average shares (shares)	144,338,000	145,313,000	146,066,000	146,765,000	147,021,000	146,716,000	−0.2%
Weighted average diluted shares (shares)	145,652,000	146,451,000	147,043,000	147,455,000	147,550,000	147,340,000	−0.1%
Gross margin	58.1%	57.5%	56.6%	55.8%	56.7%	59.4%	+2.7 pts
Operating margin	27.4%	28.3%	28.0%	26.8%	28.2%	32.8%	+4.6 pts
Net margin	21.0%	14.8%	21.8%	21.3%	21.8%	27.2%	+5.4 pts

USD billionsUpdated 30 Sep 2025 ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.